4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-040269
Director sold 585 shares at $46.76 ($27,355)
From the SEC's structured data for this filing
Trades in this filing
Sanders Corazon (Corsee) D. · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-06-30 | Sale : show line 1 in the form | −585 | $46.76 | $27,355 | 8,985 | D |
| Open-market sales · 585 sh · avg $46.76 · $27,355 | ||||||
Loading xslF345X04/doc4.xml…